The ESMO Preceptorship on Small Cell Lung Cancer (SCLC) 2026 is an advanced educational medical program taking place in Lisbon, Portugal, from June 24–25, 2026.

Co-chaired by Dr. Kersti Oselin and Dr. Giannis Mountzios, this intensive course focuses on translating the fundamental biology of SCLC into clinical practice. The academic curriculum provides a comprehensive overview of current limited and extensive-stage disease management, the clinical efficacy and safety profiles of novel therapeutic agents like T-cell engagers and antibody-drug conjugates (ADCs), and practical protocols for managing treatment-specific adverse events, such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).